Hc. Lee et al., IGF-I OF SERUM AND VITREOUS FLUID IN PATIENTS WITH DIABETIC PROLIFERATIVE RETINOPATHY, Diabetes research and clinical practice, 24(2), 1994, pp. 85-88
Vitreous fluid and serum were obtained at the time of vitrectomy from
15 subjects with diabetic proliferative retinopathy and 6 control subj
ects. The mean serum IGF-I (IGF-I level: 1 nM/l = 7.7 ng/ml) concentra
tions were 15.40 +/- 4.97 nM/l in controls and 16.24 +/- 4.32 nM/l in
diabetic patients. The mean vitreous IGF-I concentration was 1.05 +/-
0.30 nM/l in controls and 0.91 +/- 0.50 nM/l in diabetic patients. The
re were no significant differences between the two groups, and serum I
GF-I concentrations were not correlated with vitreous IGF-I concentrat
ions in the patients with diabetic proliferative retinopathy. These da
ta suggest that IGF-I may not be a risk factor for the development of
proliferative diabetic retinpathy.